DRIVIN G ROWTH - Dr. Reddy's

schedules to the balance sheet |
(All amounts in Indian Rupees thousands, except share data)
As at As at
March 31, 2002 March 31, 2001
schedule 1: share capital
Authorised
100,000,000 equity shares of Rs. 5 each
(previous year: 50,000,000 equity shares of Rs. 10 each) 500,000 500,000
Issued
76,516,148 equity shares of Rs. 5 each
(previous year: 31,588,880 equity shares of Rs. 10 each) fully paid-up 382,581 315,889
Subscribed and paid-up
76,515,948 equity shares of Rs. 5 each
(previous year: 31,588,780 equity shares of Rs. 10 each) fully paid-up 382,579 315,887
Add: Forfeited share capital (Note 3) 1 382,580 1 315,888
Share capital suspense
Nil equity shares of Rs. 5 each (previous year: 56,694 equity shares of
Rs. 10 each fully paid) issued pursuant to the scheme of amalgamation
to erstwhile members of American Remedies Limited (ARL). – 567
382,580 316,455
NOTES:
1. In the Annual General Meeting of the Company held on September 24, 2001, the shareholders approved a two-for-one share split
with an effective date of October 25, 2001. Consequently, the issued equity shares have increased to 76,516,148 shares of Rs. 5
each and subscribed and paid-up equity shares of the Company have increased to 76,515,948 shares of Rs. 5 each. All references
in the financial statements to number of shares and per share amounts of the Company’s equity shares have been presented to
reflect the increased number of equity shares outstanding resulting due to the share split.
2. Subscribed and paid-up share capital includes:
a) 34,974,400 equity shares of Rs. 5 each (previous year: 17,487,200 equity shares of Rs. 10 each) fully paid-up, allotted as bonus
shares by capitalisation of general reserve.
b) 526,124 equity shares of Rs. 5 each (previous year: 263,062 equity shares of Rs. 10 each) issued as fully paid-up, pursuant to a
scheme of amalgamation with Standard Equity Fund Limited without payments being received in cash.
c) 10,285,884 equity shares of Rs. 5 each (previous year: 5,142,942 equity shares of Rs. 10 each) allotted and 82,800 equity shares
of Rs. 5 each (previous year: 41,400 equity shares of Rs. 10 each) extinguished pursuant to the scheme of amalgamation with
erstwhile Cheminor Drugs Limited (CDL) without payments being received in cash.
d) 13,225,000 equity shares of Rs. 5 each (previous year: nil) allotted against American Depository Shares (ADS) (Refer Note 10 of
schedule 20).
e) 8,602,152 equity shares of Rs. 5 each (previous year: 4,301,076 equity shares of Rs. 10 each) allotted against Global Depository
Receipts (GDR). During the year, the outstanding GDRs have been converted to ADSs.
f) 113,388 equity shares of Rs. 5 each (previous year: nil) allotted to the erstwhile members of ARL pursuant to the scheme of
amalgamation with ARL.
3. Represents 200 equity shares of Rs. 5 each, (previous year: 100 equity shares of Rs. 10 each) amount paid up Rs. 500/-, forfeited
due to non-payment of allotment money.
DR. REDDY’S LABORATORIES LTD. | FINANCIALS | ANNUAL REPORT 2001-2002
109